| Sanofi-Aventis (Suisse) SA - Dupixent 200 mg/ 1.14 ml, solution injectable en stylo pré-rempli |
| 67661 | | 01 | | Dupixent 200 mg/ 1.14 ml | | solution injectable en stylo pré-rempli | | D11AH05 | | Dupilumab | | 04.03.2021 | | |
|
| Composition |
| dupilumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1.14 ml corresp. natrium 0.25 mg. |
| Packungsbestandteile |
| solution injectable en stylo pré-rempli | | | | | | | | Principe actif | Concentr. |
|---|
| Dupilumabum | 200mg / 1.14ml |
| | BAG: Principe actif | Concentr. |
|---|
| Dupilumabum | 200 mg |
| | | | Agents auxilliaires |
|---|
| Acidum Aceticum Glaciale | | Arginine Hydrochloride | | Histidin Hydrochloride Monohydrate | | Histidine | | Sodium Acetate Trihydrate | | Polysorbatum 80 | | Saccharum |
| |
|
|
